Assessment of myocardial fibrosis and coronary flow reserve in diabetic heart failure patients: Elucidation of pathogenesis and risk stratification by cardiac magnetic resonance

Assessment of myocardial fibrosis and coronary flow reserve in diabetic heart failure patients: Elucidation of pathogenesis and risk stratification by cardiac magnetic resonance - Assessment of myocardial fibrosis and coronary flow reserve in diabetic heart failure patients: Elucidation of pathogenesis and risk stratification by cardiac magnetic resonance

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033120

Enrollment

300

Registered

2018-07-01

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure patients with diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic heart failure patients who performed assessment of myocardial fibrosis and coronary flow reserve by cardiac magnetic resonance Non-diabetic heart failure patients will be included in this study.

Exclusion criteria

Exclusion criteria: Patients who couldn't complete MRI scan Patients having persistent left side vena cava Patients with eGFR<30ml/min/1.73m2

Design outcomes

Primary

Measure	Time frame
Assessment of myocardial fibrosis by T1 mapping and coronary flow reserve by phase contrast cine MRI of the coronary sinus Relationship between fibrosis/CFR and prognosis	—

Countries

Japan

Contacts

Public ContactShingo Kato

Kanagawa Cardiovascular and respiratory Center Department of Cardiology

shingo.m12226@gmail.com045-701-9581

Outcome results